# SSRIs vs. TCAs for Depression in ALS Patients

> **NCT02851914** · EARLY_PHASE1 · COMPLETED · sponsor: **St. Louis University** · enrollment: 2 (actual)

## Conditions studied

- Depression
- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** Tricyclic Antidepressants ("TCA")
- **DRUG:** Selective Serotonin Uptake Inhibitors ("SSRI")

## Key facts

- **NCT ID:** NCT02851914
- **Lead sponsor:** St. Louis University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07-21
- **Primary completion:** 2019-05-30
- **Final completion:** 2019-05-30
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2020-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02851914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02851914, "SSRIs vs. TCAs for Depression in ALS Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02851914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*